Dennis R. Delaney’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $597K | Hold |
16,250
| – | – | 0.21% | 45 |
|
|
2025
Q4 | $827K | Sell |
16,250
-5,020
| -24% | -$257K | 0.42% | 34 |
|
|
2025
Q3 | $1.18M | Sell |
21,270
-5,440
| -20% | -$318K | 0.59% | 38 |
|
|
2025
Q2 | $1.84M | Buy |
26,710
+5,350
| +25% | +$364K | 0.95% | 32 |
|
|
2025
Q1 | $1.48M | Buy |
21,360
+7,820
| +58% | +$646K | 0.81% | 33 |
|
|
2024
Q4 | $1.16M | Sell |
13,540
-1,015
| -7% | -$110K | 0.61% | 34 |
|
|
2024
Q3 | $1.73M | Sell |
14,555
-3,580
| -20% | -$477K | 0.89% | 33 |
|
|
2024
Q2 | $2.59M | Sell |
18,135
-5
| -0% | -$663 | 1.4% | 28 |
|
|
2024
Q1 | $2.33M | Sell |
18,140
-20
| -0.1% | -$2.38K | 1.27% | 29 |
|
|
2023
Q4 | $1.88M | Sell |
18,160
-2,500
| -12% | -$247K | 1.11% | 33 |
|
|
2023
Q3 | $1.88M | Hold |
20,660
| – | – | 1.21% | 32 |
|
|
2023
Q2 | $1.67M | Sell |
20,660
-50
| -0.2% | -$4.08K | 1.02% | 33 |
|
|
2023
Q1 | $1.65M | Sell |
20,710
-20
| -0.1% | -$1.42K | 1.41% | 30 |
|
|
2022
Q4 | $1.4M | Hold |
20,730
| – | – | 1.26% | 31 |
|
|
2022
Q3 | $1.03M | Buy |
+20,730
| New | +$1.11M | 0.99% | 34 |
|
|
2020
Q2 | $687K | Hold |
20,980
| – | – | 0.92% | 37 |
|
|
2020
Q1 | $631K | Hold |
20,980
| – | – | 0.99% | 37 |
|
|
2019
Q4 | $607K | Hold |
20,980
| – | – | 0.78% | 38 |
|
|
2019
Q3 | $542K | Hold |
20,980
| – | – | 0.74% | 38 |
|
|
2019
Q2 | $535K | Hold |
20,980
| – | – | 0.72% | 39 |
|
|
2019
Q1 | $549K | Hold |
20,980
| – | – | 0.74% | 39 |
|
|
2018
Q4 | $484K | Hold |
20,980
| – | – | 0.75% | 38 |
|
|
2018
Q3 | $495K | Hold |
20,980
| – | – | 0.65% | 39 |
|
|
2018
Q2 | $484K | Hold |
20,980
| – | – | 0.7% | 38 |
|
|
2018
Q1 | $517K | Hold |
20,980
| – | – | 0.73% | 39 |
|
|
2017
Q4 | $563K | Sell |
20,980
-50
| -0.2% | -$1.27K | 0.75% | 37 |
|
|
2017
Q3 | $506K | Hold |
21,030
| – | – | 0.98% | 31 |
|
|
2017
Q2 | $451K | Hold |
21,030
| – | – | 0.91% | 32 |
|
|
2017
Q1 | $360K | Sell |
21,030
-3,270
| -13% | -$56.9K | 0.75% | 35 |
|
|
2016
Q4 | $435K | Sell |
24,300
-120
| -0.5% | -$2.17K | 0.93% | 31 |
|
|
2016
Q3 | $508K | Sell |
24,420
-50
| -0.2% | -$1.24K | 1.08% | 29 |
|
|
2016
Q2 | $658K | Sell |
24,470
-660
| -3% | -$18.1K | 1.41% | 27 |
|
|
2016
Q1 | $681K | Hold |
25,130
| – | – | 1.48% | 25 |
|
|
2015
Q4 | $729K | Buy |
+25,130
| New | +$696K | 1.63% | 24 |
|
Other funds holding NVO
DAM
F
Dennis R. Delaney's NVO Position: Q1 2026 in Review
Dennis R. Delaney held its Novo Nordisk (NVO) position steady in Q1 2026 at 16,250 shares worth $597K. The position accounts for 0.21% of the portfolio, ranked #45.
Dennis R. Delaney first reported a position in NVO in Q4 2015 and has held it in 34 quarters since. The position peaked at $2.59M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Dennis R. Delaney held 16,250 shares of Novo Nordisk worth $597K as of Q1 2026.
- Dennis R. Delaney left its Novo Nordisk share count unchanged in Q1 2026.
- Novo Nordisk made up 0.21% of Dennis R. Delaney's portfolio in Q1 2026, its #45 holding.
- Dennis R. Delaney first reported a position in Novo Nordisk in Q4 2015 and has held it in 34 quarters since.
- Dennis R. Delaney's Novo Nordisk position peaked at $2.59M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Dennis R. Delaney's 13F filing for Q1 2026, filed 14 May 2026.